English
Home > Products > CAS NO 99-54-7

China CAS NO 99-54-7 Factory

We've been also focusing on improving upon the stuff management and QC program to make sure that we could hold fantastic gain in the fiercely-competitive enterprise for CAS NO 99-54-7,99-54-7,3,4-Dichloronitrobenzene, Honesty is our principle, professional operation is our work, service is our goal, and customers' satisfaction is our future!
CAS NO 99-54-7, We severely promise that we give all the customers with the best quality products and solutions, the most competitive prices and the most prompt delivery. We hope to win a resplendent future for customers and ourselves.

Related Products

Hot Products

  • Benzene,1,4-bis(1-methylethyl)-,homopolymer

    Benzene,1,4-bis(1-methylethyl)-,homopolymer

    Product Name:Benzene,1,4-bis(1-methylethyl)-,homopolymer
    Molecular Formula:C12H18
    Molecular Weight:162.28
    CAS Registry Number:25822-43-9
  • Bempedoic acid

    Bempedoic acid

    Product Name:Bempedoic acid
    Molecular Formula:C19H36O5
    Molecular Weight;344.49
    CAS Registry Number;738606-46-7
  • (5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone

    (5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone

    Product Name:(5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone
    Molecular Formula:C13H7BrClFO
    Molecular Weight:313.55
    CAS Registry Number:915095-85-1
  • D-Cycloserine

    D-Cycloserine

    Product Name:D-Cycloserine
    Molecular Formula:C3H6N2O2
    Molecular Weight:102.09
    CAS Registry Number:68-41-7
  • Oseltamivir HCl

    Oseltamivir HCl

    Product Name:Oseltamivir HCl
    Molecular Formula:C16H29ClN2O4
    Molecular Weight;348.87
    CAS Registry Number;204255-09-4
  • L-Norleucine

    L-Norleucine

    Product Name:L-Norleucine
    Molecular Formula:C6H13NO2
    Molecular Weight:131.17
    CAS Registry Number:327-57-1
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept